Global Lung Cancer Liquid Biops Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Lung Cancer Liquid Biops Market Size was estimated at USD 194.35 million in 2023 and is projected to reach USD 426.59 million by 2029, exhibiting a CAGR of 14.00% during the forecast period.
This report provides a deep insight into the global Lung Cancer Liquid Biops market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Liquid Biops Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Liquid Biops market in any manner.
Global Lung Cancer Liquid Biops Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biocept
EntroGen
Cynvenio Biosystems
Exosome Diagnostics
F. Hoffmann-La Roche
Clearbridge BioMedics
Bio-Rad Laboratories
Agena Bioscience
Cancer Genetics
CellMax Life
Nateras
MedGenome
OncoDNA
Genomic Health
Trovagene
Fluxion Biosciences
Biodesix
Epic Sciences
Shuwen Biotech
Personal Genome Diagnostics
Predicine
Market Segmentation (by Type)
Exosomes and RNA
CTCs and ctDNA
Market Segmentation (by Application)
Hospitals and Clinics
Physicians'Office Laboratories
Clinical Diagnostic Laboratories
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Liquid Biops Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Lung Cancer Liquid Biops Market Size was estimated at USD 194.35 million in 2023 and is projected to reach USD 426.59 million by 2029, exhibiting a CAGR of 14.00% during the forecast period.
This report provides a deep insight into the global Lung Cancer Liquid Biops market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Liquid Biops Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Liquid Biops market in any manner.
Global Lung Cancer Liquid Biops Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biocept
EntroGen
Cynvenio Biosystems
Exosome Diagnostics
F. Hoffmann-La Roche
Clearbridge BioMedics
Bio-Rad Laboratories
Agena Bioscience
Cancer Genetics
CellMax Life
Nateras
MedGenome
OncoDNA
Genomic Health
Trovagene
Fluxion Biosciences
Biodesix
Epic Sciences
Shuwen Biotech
Personal Genome Diagnostics
Predicine
Market Segmentation (by Type)
Exosomes and RNA
CTCs and ctDNA
Market Segmentation (by Application)
Hospitals and Clinics
Physicians'Office Laboratories
Clinical Diagnostic Laboratories
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Lung Cancer Liquid Biops Market
- Overview of the regional outlook of the Lung Cancer Liquid Biops Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Liquid Biops Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Lung Cancer Liquid Biops
1.2 Key Market Segments
1.2.1 Lung Cancer Liquid Biops Segment by Type
1.2.2 Lung Cancer Liquid Biops Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER LIQUID BIOPS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Liquid Biops Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Lung Cancer Liquid Biops Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER LIQUID BIOPS MARKET COMPETITIVE LANDSCAPE
3.1 Global Lung Cancer Liquid Biops Sales by Manufacturers (2019-2024)
3.2 Global Lung Cancer Liquid Biops Revenue Market Share by Manufacturers (2019-2024)
3.3 Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lung Cancer Liquid Biops Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lung Cancer Liquid Biops Sales Sites, Area Served, Product Type
3.6 Lung Cancer Liquid Biops Market Competitive Situation and Trends
3.6.1 Lung Cancer Liquid Biops Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Liquid Biops Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER LIQUID BIOPS INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Liquid Biops Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER LIQUID BIOPS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LUNG CANCER LIQUID BIOPS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Liquid Biops Sales Market Share by Type (2019-2024)
6.3 Global Lung Cancer Liquid Biops Market Size Market Share by Type (2019-2024)
6.4 Global Lung Cancer Liquid Biops Price by Type (2019-2024)
7 LUNG CANCER LIQUID BIOPS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Liquid Biops Market Sales by Application (2019-2024)
7.3 Global Lung Cancer Liquid Biops Market Size (M USD) by Application (2019-2024)
7.4 Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2019-2024)
8 LUNG CANCER LIQUID BIOPS MARKET SEGMENTATION BY REGION
8.1 Global Lung Cancer Liquid Biops Sales by Region
8.1.1 Global Lung Cancer Liquid Biops Sales by Region
8.1.2 Global Lung Cancer Liquid Biops Sales Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Liquid Biops Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Liquid Biops Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Liquid Biops Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Liquid Biops Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Liquid Biops Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Biocept
9.1.1 Biocept Lung Cancer Liquid Biops Basic Information
9.1.2 Biocept Lung Cancer Liquid Biops Product Overview
9.1.3 Biocept Lung Cancer Liquid Biops Product Market Performance
9.1.4 Biocept Business Overview
9.1.5 Biocept Lung Cancer Liquid Biops SWOT Analysis
9.1.6 Biocept Recent Developments
9.2 EntroGen
9.2.1 EntroGen Lung Cancer Liquid Biops Basic Information
9.2.2 EntroGen Lung Cancer Liquid Biops Product Overview
9.2.3 EntroGen Lung Cancer Liquid Biops Product Market Performance
9.2.4 EntroGen Business Overview
9.2.5 EntroGen Lung Cancer Liquid Biops SWOT Analysis
9.2.6 EntroGen Recent Developments
9.3 Cynvenio Biosystems
9.3.1 Cynvenio Biosystems Lung Cancer Liquid Biops Basic Information
9.3.2 Cynvenio Biosystems Lung Cancer Liquid Biops Product Overview
9.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Product Market Performance
9.3.4 Cynvenio Biosystems Lung Cancer Liquid Biops SWOT Analysis
9.3.5 Cynvenio Biosystems Business Overview
9.3.6 Cynvenio Biosystems Recent Developments
9.4 Exosome Diagnostics
9.4.1 Exosome Diagnostics Lung Cancer Liquid Biops Basic Information
9.4.2 Exosome Diagnostics Lung Cancer Liquid Biops Product Overview
9.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Product Market Performance
9.4.4 Exosome Diagnostics Business Overview
9.4.5 Exosome Diagnostics Recent Developments
9.5 F. Hoffmann-La Roche
9.5.1 F. Hoffmann-La Roche Lung Cancer Liquid Biops Basic Information
9.5.2 F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Overview
9.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Market Performance
9.5.4 F. Hoffmann-La Roche Business Overview
9.5.5 F. Hoffmann-La Roche Recent Developments
9.6 Clearbridge BioMedics
9.6.1 Clearbridge BioMedics Lung Cancer Liquid Biops Basic Information
9.6.2 Clearbridge BioMedics Lung Cancer Liquid Biops Product Overview
9.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Product Market Performance
9.6.4 Clearbridge BioMedics Business Overview
9.6.5 Clearbridge BioMedics Recent Developments
9.7 Bio-Rad Laboratories
9.7.1 Bio-Rad Laboratories Lung Cancer Liquid Biops Basic Information
9.7.2 Bio-Rad Laboratories Lung Cancer Liquid Biops Product Overview
9.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Product Market Performance
9.7.4 Bio-Rad Laboratories Business Overview
9.7.5 Bio-Rad Laboratories Recent Developments
9.8 Agena Bioscience
9.8.1 Agena Bioscience Lung Cancer Liquid Biops Basic Information
9.8.2 Agena Bioscience Lung Cancer Liquid Biops Product Overview
9.8.3 Agena Bioscience Lung Cancer Liquid Biops Product Market Performance
9.8.4 Agena Bioscience Business Overview
9.8.5 Agena Bioscience Recent Developments
9.9 Cancer Genetics
9.9.1 Cancer Genetics Lung Cancer Liquid Biops Basic Information
9.9.2 Cancer Genetics Lung Cancer Liquid Biops Product Overview
9.9.3 Cancer Genetics Lung Cancer Liquid Biops Product Market Performance
9.9.4 Cancer Genetics Business Overview
9.9.5 Cancer Genetics Recent Developments
9.10 CellMax Life
9.10.1 CellMax Life Lung Cancer Liquid Biops Basic Information
9.10.2 CellMax Life Lung Cancer Liquid Biops Product Overview
9.10.3 CellMax Life Lung Cancer Liquid Biops Product Market Performance
9.10.4 CellMax Life Business Overview
9.10.5 CellMax Life Recent Developments
9.11 Nateras
9.11.1 Nateras Lung Cancer Liquid Biops Basic Information
9.11.2 Nateras Lung Cancer Liquid Biops Product Overview
9.11.3 Nateras Lung Cancer Liquid Biops Product Market Performance
9.11.4 Nateras Business Overview
9.11.5 Nateras Recent Developments
9.12 MedGenome
9.12.1 MedGenome Lung Cancer Liquid Biops Basic Information
9.12.2 MedGenome Lung Cancer Liquid Biops Product Overview
9.12.3 MedGenome Lung Cancer Liquid Biops Product Market Performance
9.12.4 MedGenome Business Overview
9.12.5 MedGenome Recent Developments
9.13 OncoDNA
9.13.1 OncoDNA Lung Cancer Liquid Biops Basic Information
9.13.2 OncoDNA Lung Cancer Liquid Biops Product Overview
9.13.3 OncoDNA Lung Cancer Liquid Biops Product Market Performance
9.13.4 OncoDNA Business Overview
9.13.5 OncoDNA Recent Developments
9.14 Genomic Health
9.14.1 Genomic Health Lung Cancer Liquid Biops Basic Information
9.14.2 Genomic Health Lung Cancer Liquid Biops Product Overview
9.14.3 Genomic Health Lung Cancer Liquid Biops Product Market Performance
9.14.4 Genomic Health Business Overview
9.14.5 Genomic Health Recent Developments
9.15 Trovagene
9.15.1 Trovagene Lung Cancer Liquid Biops Basic Information
9.15.2 Trovagene Lung Cancer Liquid Biops Product Overview
9.15.3 Trovagene Lung Cancer Liquid Biops Product Market Performance
9.15.4 Trovagene Business Overview
9.15.5 Trovagene Recent Developments
9.16 Fluxion Biosciences
9.16.1 Fluxion Biosciences Lung Cancer Liquid Biops Basic Information
9.16.2 Fluxion Biosciences Lung Cancer Liquid Biops Product Overview
9.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Product Market Performance
9.16.4 Fluxion Biosciences Business Overview
9.16.5 Fluxion Biosciences Recent Developments
9.17 Biodesix
9.17.1 Biodesix Lung Cancer Liquid Biops Basic Information
9.17.2 Biodesix Lung Cancer Liquid Biops Product Overview
9.17.3 Biodesix Lung Cancer Liquid Biops Product Market Performance
9.17.4 Biodesix Business Overview
9.17.5 Biodesix Recent Developments
9.18 Epic Sciences
9.18.1 Epic Sciences Lung Cancer Liquid Biops Basic Information
9.18.2 Epic Sciences Lung Cancer Liquid Biops Product Overview
9.18.3 Epic Sciences Lung Cancer Liquid Biops Product Market Performance
9.18.4 Epic Sciences Business Overview
9.18.5 Epic Sciences Recent Developments
9.19 Shuwen Biotech
9.19.1 Shuwen Biotech Lung Cancer Liquid Biops Basic Information
9.19.2 Shuwen Biotech Lung Cancer Liquid Biops Product Overview
9.19.3 Shuwen Biotech Lung Cancer Liquid Biops Product Market Performance
9.19.4 Shuwen Biotech Business Overview
9.19.5 Shuwen Biotech Recent Developments
9.20 Personal Genome Diagnostics
9.20.1 Personal Genome Diagnostics Lung Cancer Liquid Biops Basic Information
9.20.2 Personal Genome Diagnostics Lung Cancer Liquid Biops Product Overview
9.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Product Market Performance
9.20.4 Personal Genome Diagnostics Business Overview
9.20.5 Personal Genome Diagnostics Recent Developments
9.21 Predicine
9.21.1 Predicine Lung Cancer Liquid Biops Basic Information
9.21.2 Predicine Lung Cancer Liquid Biops Product Overview
9.21.3 Predicine Lung Cancer Liquid Biops Product Market Performance
9.21.4 Predicine Business Overview
9.21.5 Predicine Recent Developments
10 LUNG CANCER LIQUID BIOPS MARKET FORECAST BY REGION
10.1 Global Lung Cancer Liquid Biops Market Size Forecast
10.2 Global Lung Cancer Liquid Biops Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Liquid Biops Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Liquid Biops Market Size Forecast by Region
10.2.4 South America Lung Cancer Liquid Biops Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Liquid Biops by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Lung Cancer Liquid Biops Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Lung Cancer Liquid Biops by Type (2025-2030)
11.1.2 Global Lung Cancer Liquid Biops Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Lung Cancer Liquid Biops by Type (2025-2030)
11.2 Global Lung Cancer Liquid Biops Market Forecast by Application (2025-2030)
11.2.1 Global Lung Cancer Liquid Biops Sales (K Units) Forecast by Application
11.2.2 Global Lung Cancer Liquid Biops Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Lung Cancer Liquid Biops
1.2 Key Market Segments
1.2.1 Lung Cancer Liquid Biops Segment by Type
1.2.2 Lung Cancer Liquid Biops Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER LIQUID BIOPS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Liquid Biops Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Lung Cancer Liquid Biops Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER LIQUID BIOPS MARKET COMPETITIVE LANDSCAPE
3.1 Global Lung Cancer Liquid Biops Sales by Manufacturers (2019-2024)
3.2 Global Lung Cancer Liquid Biops Revenue Market Share by Manufacturers (2019-2024)
3.3 Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lung Cancer Liquid Biops Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lung Cancer Liquid Biops Sales Sites, Area Served, Product Type
3.6 Lung Cancer Liquid Biops Market Competitive Situation and Trends
3.6.1 Lung Cancer Liquid Biops Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Liquid Biops Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER LIQUID BIOPS INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Liquid Biops Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER LIQUID BIOPS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LUNG CANCER LIQUID BIOPS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Liquid Biops Sales Market Share by Type (2019-2024)
6.3 Global Lung Cancer Liquid Biops Market Size Market Share by Type (2019-2024)
6.4 Global Lung Cancer Liquid Biops Price by Type (2019-2024)
7 LUNG CANCER LIQUID BIOPS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Liquid Biops Market Sales by Application (2019-2024)
7.3 Global Lung Cancer Liquid Biops Market Size (M USD) by Application (2019-2024)
7.4 Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2019-2024)
8 LUNG CANCER LIQUID BIOPS MARKET SEGMENTATION BY REGION
8.1 Global Lung Cancer Liquid Biops Sales by Region
8.1.1 Global Lung Cancer Liquid Biops Sales by Region
8.1.2 Global Lung Cancer Liquid Biops Sales Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Liquid Biops Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Liquid Biops Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Liquid Biops Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Liquid Biops Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Liquid Biops Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Biocept
9.1.1 Biocept Lung Cancer Liquid Biops Basic Information
9.1.2 Biocept Lung Cancer Liquid Biops Product Overview
9.1.3 Biocept Lung Cancer Liquid Biops Product Market Performance
9.1.4 Biocept Business Overview
9.1.5 Biocept Lung Cancer Liquid Biops SWOT Analysis
9.1.6 Biocept Recent Developments
9.2 EntroGen
9.2.1 EntroGen Lung Cancer Liquid Biops Basic Information
9.2.2 EntroGen Lung Cancer Liquid Biops Product Overview
9.2.3 EntroGen Lung Cancer Liquid Biops Product Market Performance
9.2.4 EntroGen Business Overview
9.2.5 EntroGen Lung Cancer Liquid Biops SWOT Analysis
9.2.6 EntroGen Recent Developments
9.3 Cynvenio Biosystems
9.3.1 Cynvenio Biosystems Lung Cancer Liquid Biops Basic Information
9.3.2 Cynvenio Biosystems Lung Cancer Liquid Biops Product Overview
9.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Product Market Performance
9.3.4 Cynvenio Biosystems Lung Cancer Liquid Biops SWOT Analysis
9.3.5 Cynvenio Biosystems Business Overview
9.3.6 Cynvenio Biosystems Recent Developments
9.4 Exosome Diagnostics
9.4.1 Exosome Diagnostics Lung Cancer Liquid Biops Basic Information
9.4.2 Exosome Diagnostics Lung Cancer Liquid Biops Product Overview
9.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Product Market Performance
9.4.4 Exosome Diagnostics Business Overview
9.4.5 Exosome Diagnostics Recent Developments
9.5 F. Hoffmann-La Roche
9.5.1 F. Hoffmann-La Roche Lung Cancer Liquid Biops Basic Information
9.5.2 F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Overview
9.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Market Performance
9.5.4 F. Hoffmann-La Roche Business Overview
9.5.5 F. Hoffmann-La Roche Recent Developments
9.6 Clearbridge BioMedics
9.6.1 Clearbridge BioMedics Lung Cancer Liquid Biops Basic Information
9.6.2 Clearbridge BioMedics Lung Cancer Liquid Biops Product Overview
9.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Product Market Performance
9.6.4 Clearbridge BioMedics Business Overview
9.6.5 Clearbridge BioMedics Recent Developments
9.7 Bio-Rad Laboratories
9.7.1 Bio-Rad Laboratories Lung Cancer Liquid Biops Basic Information
9.7.2 Bio-Rad Laboratories Lung Cancer Liquid Biops Product Overview
9.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Product Market Performance
9.7.4 Bio-Rad Laboratories Business Overview
9.7.5 Bio-Rad Laboratories Recent Developments
9.8 Agena Bioscience
9.8.1 Agena Bioscience Lung Cancer Liquid Biops Basic Information
9.8.2 Agena Bioscience Lung Cancer Liquid Biops Product Overview
9.8.3 Agena Bioscience Lung Cancer Liquid Biops Product Market Performance
9.8.4 Agena Bioscience Business Overview
9.8.5 Agena Bioscience Recent Developments
9.9 Cancer Genetics
9.9.1 Cancer Genetics Lung Cancer Liquid Biops Basic Information
9.9.2 Cancer Genetics Lung Cancer Liquid Biops Product Overview
9.9.3 Cancer Genetics Lung Cancer Liquid Biops Product Market Performance
9.9.4 Cancer Genetics Business Overview
9.9.5 Cancer Genetics Recent Developments
9.10 CellMax Life
9.10.1 CellMax Life Lung Cancer Liquid Biops Basic Information
9.10.2 CellMax Life Lung Cancer Liquid Biops Product Overview
9.10.3 CellMax Life Lung Cancer Liquid Biops Product Market Performance
9.10.4 CellMax Life Business Overview
9.10.5 CellMax Life Recent Developments
9.11 Nateras
9.11.1 Nateras Lung Cancer Liquid Biops Basic Information
9.11.2 Nateras Lung Cancer Liquid Biops Product Overview
9.11.3 Nateras Lung Cancer Liquid Biops Product Market Performance
9.11.4 Nateras Business Overview
9.11.5 Nateras Recent Developments
9.12 MedGenome
9.12.1 MedGenome Lung Cancer Liquid Biops Basic Information
9.12.2 MedGenome Lung Cancer Liquid Biops Product Overview
9.12.3 MedGenome Lung Cancer Liquid Biops Product Market Performance
9.12.4 MedGenome Business Overview
9.12.5 MedGenome Recent Developments
9.13 OncoDNA
9.13.1 OncoDNA Lung Cancer Liquid Biops Basic Information
9.13.2 OncoDNA Lung Cancer Liquid Biops Product Overview
9.13.3 OncoDNA Lung Cancer Liquid Biops Product Market Performance
9.13.4 OncoDNA Business Overview
9.13.5 OncoDNA Recent Developments
9.14 Genomic Health
9.14.1 Genomic Health Lung Cancer Liquid Biops Basic Information
9.14.2 Genomic Health Lung Cancer Liquid Biops Product Overview
9.14.3 Genomic Health Lung Cancer Liquid Biops Product Market Performance
9.14.4 Genomic Health Business Overview
9.14.5 Genomic Health Recent Developments
9.15 Trovagene
9.15.1 Trovagene Lung Cancer Liquid Biops Basic Information
9.15.2 Trovagene Lung Cancer Liquid Biops Product Overview
9.15.3 Trovagene Lung Cancer Liquid Biops Product Market Performance
9.15.4 Trovagene Business Overview
9.15.5 Trovagene Recent Developments
9.16 Fluxion Biosciences
9.16.1 Fluxion Biosciences Lung Cancer Liquid Biops Basic Information
9.16.2 Fluxion Biosciences Lung Cancer Liquid Biops Product Overview
9.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Product Market Performance
9.16.4 Fluxion Biosciences Business Overview
9.16.5 Fluxion Biosciences Recent Developments
9.17 Biodesix
9.17.1 Biodesix Lung Cancer Liquid Biops Basic Information
9.17.2 Biodesix Lung Cancer Liquid Biops Product Overview
9.17.3 Biodesix Lung Cancer Liquid Biops Product Market Performance
9.17.4 Biodesix Business Overview
9.17.5 Biodesix Recent Developments
9.18 Epic Sciences
9.18.1 Epic Sciences Lung Cancer Liquid Biops Basic Information
9.18.2 Epic Sciences Lung Cancer Liquid Biops Product Overview
9.18.3 Epic Sciences Lung Cancer Liquid Biops Product Market Performance
9.18.4 Epic Sciences Business Overview
9.18.5 Epic Sciences Recent Developments
9.19 Shuwen Biotech
9.19.1 Shuwen Biotech Lung Cancer Liquid Biops Basic Information
9.19.2 Shuwen Biotech Lung Cancer Liquid Biops Product Overview
9.19.3 Shuwen Biotech Lung Cancer Liquid Biops Product Market Performance
9.19.4 Shuwen Biotech Business Overview
9.19.5 Shuwen Biotech Recent Developments
9.20 Personal Genome Diagnostics
9.20.1 Personal Genome Diagnostics Lung Cancer Liquid Biops Basic Information
9.20.2 Personal Genome Diagnostics Lung Cancer Liquid Biops Product Overview
9.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Product Market Performance
9.20.4 Personal Genome Diagnostics Business Overview
9.20.5 Personal Genome Diagnostics Recent Developments
9.21 Predicine
9.21.1 Predicine Lung Cancer Liquid Biops Basic Information
9.21.2 Predicine Lung Cancer Liquid Biops Product Overview
9.21.3 Predicine Lung Cancer Liquid Biops Product Market Performance
9.21.4 Predicine Business Overview
9.21.5 Predicine Recent Developments
10 LUNG CANCER LIQUID BIOPS MARKET FORECAST BY REGION
10.1 Global Lung Cancer Liquid Biops Market Size Forecast
10.2 Global Lung Cancer Liquid Biops Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Liquid Biops Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Liquid Biops Market Size Forecast by Region
10.2.4 South America Lung Cancer Liquid Biops Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Liquid Biops by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Lung Cancer Liquid Biops Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Lung Cancer Liquid Biops by Type (2025-2030)
11.1.2 Global Lung Cancer Liquid Biops Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Lung Cancer Liquid Biops by Type (2025-2030)
11.2 Global Lung Cancer Liquid Biops Market Forecast by Application (2025-2030)
11.2.1 Global Lung Cancer Liquid Biops Sales (K Units) Forecast by Application
11.2.2 Global Lung Cancer Liquid Biops Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Liquid Biops Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Liquid Biops Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Lung Cancer Liquid Biops Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Lung Cancer Liquid Biops Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Lung Cancer Liquid Biops Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2022)
Table 10. Global Market Lung Cancer Liquid Biops Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Lung Cancer Liquid Biops Sales Sites and Area Served
Table 12. Manufacturers Lung Cancer Liquid Biops Product Type
Table 13. Global Lung Cancer Liquid Biops Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Lung Cancer Liquid Biops
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lung Cancer Liquid Biops Market Challenges
Table 22. Global Lung Cancer Liquid Biops Sales by Type (K Units)
Table 23. Global Lung Cancer Liquid Biops Market Size by Type (M USD)
Table 24. Global Lung Cancer Liquid Biops Sales (K Units) by Type (2019-2024)
Table 25. Global Lung Cancer Liquid Biops Sales Market Share by Type (2019-2024)
Table 26. Global Lung Cancer Liquid Biops Market Size (M USD) by Type (2019-2024)
Table 27. Global Lung Cancer Liquid Biops Market Size Share by Type (2019-2024)
Table 28. Global Lung Cancer Liquid Biops Price (USD/Unit) by Type (2019-2024)
Table 29. Global Lung Cancer Liquid Biops Sales (K Units) by Application
Table 30. Global Lung Cancer Liquid Biops Market Size by Application
Table 31. Global Lung Cancer Liquid Biops Sales by Application (2019-2024) & (K Units)
Table 32. Global Lung Cancer Liquid Biops Sales Market Share by Application (2019-2024)
Table 33. Global Lung Cancer Liquid Biops Sales by Application (2019-2024) & (M USD)
Table 34. Global Lung Cancer Liquid Biops Market Share by Application (2019-2024)
Table 35. Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2019-2024)
Table 36. Global Lung Cancer Liquid Biops Sales by Region (2019-2024) & (K Units)
Table 37. Global Lung Cancer Liquid Biops Sales Market Share by Region (2019-2024)
Table 38. North America Lung Cancer Liquid Biops Sales by Country (2019-2024) & (K Units)
Table 39. Europe Lung Cancer Liquid Biops Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Lung Cancer Liquid Biops Sales by Region (2019-2024) & (K Units)
Table 41. South America Lung Cancer Liquid Biops Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Lung Cancer Liquid Biops Sales by Region (2019-2024) & (K Units)
Table 43. Biocept Lung Cancer Liquid Biops Basic Information
Table 44. Biocept Lung Cancer Liquid Biops Product Overview
Table 45. Biocept Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Biocept Business Overview
Table 47. Biocept Lung Cancer Liquid Biops SWOT Analysis
Table 48. Biocept Recent Developments
Table 49. EntroGen Lung Cancer Liquid Biops Basic Information
Table 50. EntroGen Lung Cancer Liquid Biops Product Overview
Table 51. EntroGen Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. EntroGen Business Overview
Table 53. EntroGen Lung Cancer Liquid Biops SWOT Analysis
Table 54. EntroGen Recent Developments
Table 55. Cynvenio Biosystems Lung Cancer Liquid Biops Basic Information
Table 56. Cynvenio Biosystems Lung Cancer Liquid Biops Product Overview
Table 57. Cynvenio Biosystems Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Cynvenio Biosystems Lung Cancer Liquid Biops SWOT Analysis
Table 59. Cynvenio Biosystems Business Overview
Table 60. Cynvenio Biosystems Recent Developments
Table 61. Exosome Diagnostics Lung Cancer Liquid Biops Basic Information
Table 62. Exosome Diagnostics Lung Cancer Liquid Biops Product Overview
Table 63. Exosome Diagnostics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Exosome Diagnostics Business Overview
Table 65. Exosome Diagnostics Recent Developments
Table 66. F. Hoffmann-La Roche Lung Cancer Liquid Biops Basic Information
Table 67. F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Overview
Table 68. F. Hoffmann-La Roche Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. F. Hoffmann-La Roche Business Overview
Table 70. F. Hoffmann-La Roche Recent Developments
Table 71. Clearbridge BioMedics Lung Cancer Liquid Biops Basic Information
Table 72. Clearbridge BioMedics Lung Cancer Liquid Biops Product Overview
Table 73. Clearbridge BioMedics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Clearbridge BioMedics Business Overview
Table 75. Clearbridge BioMedics Recent Developments
Table 76. Bio-Rad Laboratories Lung Cancer Liquid Biops Basic Information
Table 77. Bio-Rad Laboratories Lung Cancer Liquid Biops Product Overview
Table 78. Bio-Rad Laboratories Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Bio-Rad Laboratories Business Overview
Table 80. Bio-Rad Laboratories Recent Developments
Table 81. Agena Bioscience Lung Cancer Liquid Biops Basic Information
Table 82. Agena Bioscience Lung Cancer Liquid Biops Product Overview
Table 83. Agena Bioscience Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Agena Bioscience Business Overview
Table 85. Agena Bioscience Recent Developments
Table 86. Cancer Genetics Lung Cancer Liquid Biops Basic Information
Table 87. Cancer Genetics Lung Cancer Liquid Biops Product Overview
Table 88. Cancer Genetics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Cancer Genetics Business Overview
Table 90. Cancer Genetics Recent Developments
Table 91. CellMax Life Lung Cancer Liquid Biops Basic Information
Table 92. CellMax Life Lung Cancer Liquid Biops Product Overview
Table 93. CellMax Life Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. CellMax Life Business Overview
Table 95. CellMax Life Recent Developments
Table 96. Nateras Lung Cancer Liquid Biops Basic Information
Table 97. Nateras Lung Cancer Liquid Biops Product Overview
Table 98. Nateras Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Nateras Business Overview
Table 100. Nateras Recent Developments
Table 101. MedGenome Lung Cancer Liquid Biops Basic Information
Table 102. MedGenome Lung Cancer Liquid Biops Product Overview
Table 103. MedGenome Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. MedGenome Business Overview
Table 105. MedGenome Recent Developments
Table 106. OncoDNA Lung Cancer Liquid Biops Basic Information
Table 107. OncoDNA Lung Cancer Liquid Biops Product Overview
Table 108. OncoDNA Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. OncoDNA Business Overview
Table 110. OncoDNA Recent Developments
Table 111. Genomic Health Lung Cancer Liquid Biops Basic Information
Table 112. Genomic Health Lung Cancer Liquid Biops Product Overview
Table 113. Genomic Health Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Genomic Health Business Overview
Table 115. Genomic Health Recent Developments
Table 116. Trovagene Lung Cancer Liquid Biops Basic Information
Table 117. Trovagene Lung Cancer Liquid Biops Product Overview
Table 118. Trovagene Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Trovagene Business Overview
Table 120. Trovagene Recent Developments
Table 121. Fluxion Biosciences Lung Cancer Liquid Biops Basic Information
Table 122. Fluxion Biosciences Lung Cancer Liquid Biops Product Overview
Table 123. Fluxion Biosciences Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Fluxion Biosciences Business Overview
Table 125. Fluxion Biosciences Recent Developments
Table 126. Biodesix Lung Cancer Liquid Biops Basic Information
Table 127. Biodesix Lung Cancer Liquid Biops Product Overview
Table 128. Biodesix Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Biodesix Business Overview
Table 130. Biodesix Recent Developments
Table 131. Epic Sciences Lung Cancer Liquid Biops Basic Information
Table 132. Epic Sciences Lung Cancer Liquid Biops Product Overview
Table 133. Epic Sciences Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Epic Sciences Business Overview
Table 135. Epic Sciences Recent Developments
Table 136. Shuwen Biotech Lung Cancer Liquid Biops Basic Information
Table 137. Shuwen Biotech Lung Cancer Liquid Biops Product Overview
Table 138. Shuwen Biotech Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Shuwen Biotech Business Overview
Table 140. Shuwen Biotech Recent Developments
Table 141. Personal Genome Diagnostics Lung Cancer Liquid Biops Basic Information
Table 142. Personal Genome Diagnostics Lung Cancer Liquid Biops Product Overview
Table 143. Personal Genome Diagnostics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Personal Genome Diagnostics Business Overview
Table 145. Personal Genome Diagnostics Recent Developments
Table 146. Predicine Lung Cancer Liquid Biops Basic Information
Table 147. Predicine Lung Cancer Liquid Biops Product Overview
Table 148. Predicine Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Predicine Business Overview
Table 150. Predicine Recent Developments
Table 151. Global Lung Cancer Liquid Biops Sales Forecast by Region (2025-2030) & (K Units)
Table 152. Global Lung Cancer Liquid Biops Market Size Forecast by Region (2025-2030) & (M USD)
Table 153. North America Lung Cancer Liquid Biops Sales Forecast by Country (2025-2030) & (K Units)
Table 154. North America Lung Cancer Liquid Biops Market Size Forecast by Country (2025-2030) & (M USD)
Table 155. Europe Lung Cancer Liquid Biops Sales Forecast by Country (2025-2030) & (K Units)
Table 156. Europe Lung Cancer Liquid Biops Market Size Forecast by Country (2025-2030) & (M USD)
Table 157. Asia Pacific Lung Cancer Liquid Biops Sales Forecast by Region (2025-2030) & (K Units)
Table 158. Asia Pacific Lung Cancer Liquid Biops Market Size Forecast by Region (2025-2030) & (M USD)
Table 159. South America Lung Cancer Liquid Biops Sales Forecast by Country (2025-2030) & (K Units)
Table 160. South America Lung Cancer Liquid Biops Market Size Forecast by Country (2025-2030) & (M USD)
Table 161. Middle East and Africa Lung Cancer Liquid Biops Consumption Forecast by Country (2025-2030) & (Units)
Table 162. Middle East and Africa Lung Cancer Liquid Biops Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Global Lung Cancer Liquid Biops Sales Forecast by Type (2025-2030) & (K Units)
Table 164. Global Lung Cancer Liquid Biops Market Size Forecast by Type (2025-2030) & (M USD)
Table 165. Global Lung Cancer Liquid Biops Price Forecast by Type (2025-2030) & (USD/Unit)
Table 166. Global Lung Cancer Liquid Biops Sales (K Units) Forecast by Application (2025-2030)
Table 167. Global Lung Cancer Liquid Biops Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Liquid Biops Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Liquid Biops Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Lung Cancer Liquid Biops Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Lung Cancer Liquid Biops Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Lung Cancer Liquid Biops Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2022)
Table 10. Global Market Lung Cancer Liquid Biops Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Lung Cancer Liquid Biops Sales Sites and Area Served
Table 12. Manufacturers Lung Cancer Liquid Biops Product Type
Table 13. Global Lung Cancer Liquid Biops Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Lung Cancer Liquid Biops
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lung Cancer Liquid Biops Market Challenges
Table 22. Global Lung Cancer Liquid Biops Sales by Type (K Units)
Table 23. Global Lung Cancer Liquid Biops Market Size by Type (M USD)
Table 24. Global Lung Cancer Liquid Biops Sales (K Units) by Type (2019-2024)
Table 25. Global Lung Cancer Liquid Biops Sales Market Share by Type (2019-2024)
Table 26. Global Lung Cancer Liquid Biops Market Size (M USD) by Type (2019-2024)
Table 27. Global Lung Cancer Liquid Biops Market Size Share by Type (2019-2024)
Table 28. Global Lung Cancer Liquid Biops Price (USD/Unit) by Type (2019-2024)
Table 29. Global Lung Cancer Liquid Biops Sales (K Units) by Application
Table 30. Global Lung Cancer Liquid Biops Market Size by Application
Table 31. Global Lung Cancer Liquid Biops Sales by Application (2019-2024) & (K Units)
Table 32. Global Lung Cancer Liquid Biops Sales Market Share by Application (2019-2024)
Table 33. Global Lung Cancer Liquid Biops Sales by Application (2019-2024) & (M USD)
Table 34. Global Lung Cancer Liquid Biops Market Share by Application (2019-2024)
Table 35. Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2019-2024)
Table 36. Global Lung Cancer Liquid Biops Sales by Region (2019-2024) & (K Units)
Table 37. Global Lung Cancer Liquid Biops Sales Market Share by Region (2019-2024)
Table 38. North America Lung Cancer Liquid Biops Sales by Country (2019-2024) & (K Units)
Table 39. Europe Lung Cancer Liquid Biops Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Lung Cancer Liquid Biops Sales by Region (2019-2024) & (K Units)
Table 41. South America Lung Cancer Liquid Biops Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Lung Cancer Liquid Biops Sales by Region (2019-2024) & (K Units)
Table 43. Biocept Lung Cancer Liquid Biops Basic Information
Table 44. Biocept Lung Cancer Liquid Biops Product Overview
Table 45. Biocept Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Biocept Business Overview
Table 47. Biocept Lung Cancer Liquid Biops SWOT Analysis
Table 48. Biocept Recent Developments
Table 49. EntroGen Lung Cancer Liquid Biops Basic Information
Table 50. EntroGen Lung Cancer Liquid Biops Product Overview
Table 51. EntroGen Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. EntroGen Business Overview
Table 53. EntroGen Lung Cancer Liquid Biops SWOT Analysis
Table 54. EntroGen Recent Developments
Table 55. Cynvenio Biosystems Lung Cancer Liquid Biops Basic Information
Table 56. Cynvenio Biosystems Lung Cancer Liquid Biops Product Overview
Table 57. Cynvenio Biosystems Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Cynvenio Biosystems Lung Cancer Liquid Biops SWOT Analysis
Table 59. Cynvenio Biosystems Business Overview
Table 60. Cynvenio Biosystems Recent Developments
Table 61. Exosome Diagnostics Lung Cancer Liquid Biops Basic Information
Table 62. Exosome Diagnostics Lung Cancer Liquid Biops Product Overview
Table 63. Exosome Diagnostics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Exosome Diagnostics Business Overview
Table 65. Exosome Diagnostics Recent Developments
Table 66. F. Hoffmann-La Roche Lung Cancer Liquid Biops Basic Information
Table 67. F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Overview
Table 68. F. Hoffmann-La Roche Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. F. Hoffmann-La Roche Business Overview
Table 70. F. Hoffmann-La Roche Recent Developments
Table 71. Clearbridge BioMedics Lung Cancer Liquid Biops Basic Information
Table 72. Clearbridge BioMedics Lung Cancer Liquid Biops Product Overview
Table 73. Clearbridge BioMedics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Clearbridge BioMedics Business Overview
Table 75. Clearbridge BioMedics Recent Developments
Table 76. Bio-Rad Laboratories Lung Cancer Liquid Biops Basic Information
Table 77. Bio-Rad Laboratories Lung Cancer Liquid Biops Product Overview
Table 78. Bio-Rad Laboratories Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Bio-Rad Laboratories Business Overview
Table 80. Bio-Rad Laboratories Recent Developments
Table 81. Agena Bioscience Lung Cancer Liquid Biops Basic Information
Table 82. Agena Bioscience Lung Cancer Liquid Biops Product Overview
Table 83. Agena Bioscience Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Agena Bioscience Business Overview
Table 85. Agena Bioscience Recent Developments
Table 86. Cancer Genetics Lung Cancer Liquid Biops Basic Information
Table 87. Cancer Genetics Lung Cancer Liquid Biops Product Overview
Table 88. Cancer Genetics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Cancer Genetics Business Overview
Table 90. Cancer Genetics Recent Developments
Table 91. CellMax Life Lung Cancer Liquid Biops Basic Information
Table 92. CellMax Life Lung Cancer Liquid Biops Product Overview
Table 93. CellMax Life Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. CellMax Life Business Overview
Table 95. CellMax Life Recent Developments
Table 96. Nateras Lung Cancer Liquid Biops Basic Information
Table 97. Nateras Lung Cancer Liquid Biops Product Overview
Table 98. Nateras Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Nateras Business Overview
Table 100. Nateras Recent Developments
Table 101. MedGenome Lung Cancer Liquid Biops Basic Information
Table 102. MedGenome Lung Cancer Liquid Biops Product Overview
Table 103. MedGenome Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. MedGenome Business Overview
Table 105. MedGenome Recent Developments
Table 106. OncoDNA Lung Cancer Liquid Biops Basic Information
Table 107. OncoDNA Lung Cancer Liquid Biops Product Overview
Table 108. OncoDNA Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. OncoDNA Business Overview
Table 110. OncoDNA Recent Developments
Table 111. Genomic Health Lung Cancer Liquid Biops Basic Information
Table 112. Genomic Health Lung Cancer Liquid Biops Product Overview
Table 113. Genomic Health Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Genomic Health Business Overview
Table 115. Genomic Health Recent Developments
Table 116. Trovagene Lung Cancer Liquid Biops Basic Information
Table 117. Trovagene Lung Cancer Liquid Biops Product Overview
Table 118. Trovagene Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Trovagene Business Overview
Table 120. Trovagene Recent Developments
Table 121. Fluxion Biosciences Lung Cancer Liquid Biops Basic Information
Table 122. Fluxion Biosciences Lung Cancer Liquid Biops Product Overview
Table 123. Fluxion Biosciences Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Fluxion Biosciences Business Overview
Table 125. Fluxion Biosciences Recent Developments
Table 126. Biodesix Lung Cancer Liquid Biops Basic Information
Table 127. Biodesix Lung Cancer Liquid Biops Product Overview
Table 128. Biodesix Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Biodesix Business Overview
Table 130. Biodesix Recent Developments
Table 131. Epic Sciences Lung Cancer Liquid Biops Basic Information
Table 132. Epic Sciences Lung Cancer Liquid Biops Product Overview
Table 133. Epic Sciences Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Epic Sciences Business Overview
Table 135. Epic Sciences Recent Developments
Table 136. Shuwen Biotech Lung Cancer Liquid Biops Basic Information
Table 137. Shuwen Biotech Lung Cancer Liquid Biops Product Overview
Table 138. Shuwen Biotech Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Shuwen Biotech Business Overview
Table 140. Shuwen Biotech Recent Developments
Table 141. Personal Genome Diagnostics Lung Cancer Liquid Biops Basic Information
Table 142. Personal Genome Diagnostics Lung Cancer Liquid Biops Product Overview
Table 143. Personal Genome Diagnostics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Personal Genome Diagnostics Business Overview
Table 145. Personal Genome Diagnostics Recent Developments
Table 146. Predicine Lung Cancer Liquid Biops Basic Information
Table 147. Predicine Lung Cancer Liquid Biops Product Overview
Table 148. Predicine Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Predicine Business Overview
Table 150. Predicine Recent Developments
Table 151. Global Lung Cancer Liquid Biops Sales Forecast by Region (2025-2030) & (K Units)
Table 152. Global Lung Cancer Liquid Biops Market Size Forecast by Region (2025-2030) & (M USD)
Table 153. North America Lung Cancer Liquid Biops Sales Forecast by Country (2025-2030) & (K Units)
Table 154. North America Lung Cancer Liquid Biops Market Size Forecast by Country (2025-2030) & (M USD)
Table 155. Europe Lung Cancer Liquid Biops Sales Forecast by Country (2025-2030) & (K Units)
Table 156. Europe Lung Cancer Liquid Biops Market Size Forecast by Country (2025-2030) & (M USD)
Table 157. Asia Pacific Lung Cancer Liquid Biops Sales Forecast by Region (2025-2030) & (K Units)
Table 158. Asia Pacific Lung Cancer Liquid Biops Market Size Forecast by Region (2025-2030) & (M USD)
Table 159. South America Lung Cancer Liquid Biops Sales Forecast by Country (2025-2030) & (K Units)
Table 160. South America Lung Cancer Liquid Biops Market Size Forecast by Country (2025-2030) & (M USD)
Table 161. Middle East and Africa Lung Cancer Liquid Biops Consumption Forecast by Country (2025-2030) & (Units)
Table 162. Middle East and Africa Lung Cancer Liquid Biops Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Global Lung Cancer Liquid Biops Sales Forecast by Type (2025-2030) & (K Units)
Table 164. Global Lung Cancer Liquid Biops Market Size Forecast by Type (2025-2030) & (M USD)
Table 165. Global Lung Cancer Liquid Biops Price Forecast by Type (2025-2030) & (USD/Unit)
Table 166. Global Lung Cancer Liquid Biops Sales (K Units) Forecast by Application (2025-2030)
Table 167. Global Lung Cancer Liquid Biops Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Lung Cancer Liquid Biops
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Liquid Biops Market Size (M USD), 2019-2030
Figure 5. Global Lung Cancer Liquid Biops Market Size (M USD) (2019-2030)
Figure 6. Global Lung Cancer Liquid Biops Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Liquid Biops Market Size by Country (M USD)
Figure 11. Lung Cancer Liquid Biops Sales Share by Manufacturers in 2023
Figure 12. Global Lung Cancer Liquid Biops Revenue Share by Manufacturers in 2023
Figure 13. Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Lung Cancer Liquid Biops Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Liquid Biops Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Lung Cancer Liquid Biops Market Share by Type
Figure 18. Sales Market Share of Lung Cancer Liquid Biops by Type (2019-2024)
Figure 19. Sales Market Share of Lung Cancer Liquid Biops by Type in 2023
Figure 20. Market Size Share of Lung Cancer Liquid Biops by Type (2019-2024)
Figure 21. Market Size Market Share of Lung Cancer Liquid Biops by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Lung Cancer Liquid Biops Market Share by Application
Figure 24. Global Lung Cancer Liquid Biops Sales Market Share by Application (2019-2024)
Figure 25. Global Lung Cancer Liquid Biops Sales Market Share by Application in 2023
Figure 26. Global Lung Cancer Liquid Biops Market Share by Application (2019-2024)
Figure 27. Global Lung Cancer Liquid Biops Market Share by Application in 2023
Figure 28. Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2019-2024)
Figure 29. Global Lung Cancer Liquid Biops Sales Market Share by Region (2019-2024)
Figure 30. North America Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Lung Cancer Liquid Biops Sales Market Share by Country in 2023
Figure 32. U.S. Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Lung Cancer Liquid Biops Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Lung Cancer Liquid Biops Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Lung Cancer Liquid Biops Sales Market Share by Country in 2023
Figure 37. Germany Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Lung Cancer Liquid Biops Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Lung Cancer Liquid Biops Sales Market Share by Region in 2023
Figure 44. China Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Lung Cancer Liquid Biops Sales and Growth Rate (K Units)
Figure 50. South America Lung Cancer Liquid Biops Sales Market Share by Country in 2023
Figure 51. Brazil Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Lung Cancer Liquid Biops Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Lung Cancer Liquid Biops Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Lung Cancer Liquid Biops Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Lung Cancer Liquid Biops Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Lung Cancer Liquid Biops Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Lung Cancer Liquid Biops Market Share Forecast by Type (2025-2030)
Figure 65. Global Lung Cancer Liquid Biops Sales Forecast by Application (2025-2030)
Figure 66. Global Lung Cancer Liquid Biops Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Lung Cancer Liquid Biops
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Liquid Biops Market Size (M USD), 2019-2030
Figure 5. Global Lung Cancer Liquid Biops Market Size (M USD) (2019-2030)
Figure 6. Global Lung Cancer Liquid Biops Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Liquid Biops Market Size by Country (M USD)
Figure 11. Lung Cancer Liquid Biops Sales Share by Manufacturers in 2023
Figure 12. Global Lung Cancer Liquid Biops Revenue Share by Manufacturers in 2023
Figure 13. Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Lung Cancer Liquid Biops Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Liquid Biops Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Lung Cancer Liquid Biops Market Share by Type
Figure 18. Sales Market Share of Lung Cancer Liquid Biops by Type (2019-2024)
Figure 19. Sales Market Share of Lung Cancer Liquid Biops by Type in 2023
Figure 20. Market Size Share of Lung Cancer Liquid Biops by Type (2019-2024)
Figure 21. Market Size Market Share of Lung Cancer Liquid Biops by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Lung Cancer Liquid Biops Market Share by Application
Figure 24. Global Lung Cancer Liquid Biops Sales Market Share by Application (2019-2024)
Figure 25. Global Lung Cancer Liquid Biops Sales Market Share by Application in 2023
Figure 26. Global Lung Cancer Liquid Biops Market Share by Application (2019-2024)
Figure 27. Global Lung Cancer Liquid Biops Market Share by Application in 2023
Figure 28. Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2019-2024)
Figure 29. Global Lung Cancer Liquid Biops Sales Market Share by Region (2019-2024)
Figure 30. North America Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Lung Cancer Liquid Biops Sales Market Share by Country in 2023
Figure 32. U.S. Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Lung Cancer Liquid Biops Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Lung Cancer Liquid Biops Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Lung Cancer Liquid Biops Sales Market Share by Country in 2023
Figure 37. Germany Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Lung Cancer Liquid Biops Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Lung Cancer Liquid Biops Sales Market Share by Region in 2023
Figure 44. China Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Lung Cancer Liquid Biops Sales and Growth Rate (K Units)
Figure 50. South America Lung Cancer Liquid Biops Sales Market Share by Country in 2023
Figure 51. Brazil Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Lung Cancer Liquid Biops Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Lung Cancer Liquid Biops Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Lung Cancer Liquid Biops Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Lung Cancer Liquid Biops Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Lung Cancer Liquid Biops Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Lung Cancer Liquid Biops Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Lung Cancer Liquid Biops Market Share Forecast by Type (2025-2030)
Figure 65. Global Lung Cancer Liquid Biops Sales Forecast by Application (2025-2030)
Figure 66. Global Lung Cancer Liquid Biops Market Share Forecast by Application (2025-2030)
